Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q19596736> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- Q19596736 subject Q20870725.
- Q19596736 subject Q6184475.
- Q19596736 subject Q7145142.
- Q19596736 subject Q7215865.
- Q19596736 subject Q8367244.
- Q19596736 subject Q8569934.
- Q19596736 subject Q8844648.
- Q19596736 subject Q8919936.
- Q19596736 subject Q9546190.
- Q19596736 abstract "Dasolampanel (INN, USAN, code name NGX-426) is an orally bioavailable analog of tezampanel and thereby competitive antagonist of the AMPA and kainate receptors which was under development by Raptor Pharmaceuticals/Torrey Pines Therapeutics for the treatment of chronic pain conditions including neuropathic pain and migraine. It was developed as a follow-on compound to tezampanel, as tezampanel is not bioavailable orally and must be administered by intravenous injection, but ultimately neither drug was ever marketed.".
- Q19596736 atcPrefix "None".
- Q19596736 casNumber "503294-13-1".
- Q19596736 fdaUniiCode "1P85D6BE9K".
- Q19596736 iupacName "(3S,4aS,6S,8aR)-6-(3-Chloro-2-(1H-tetrazol-5-yl)phenoxy)decahydroisoquinoline-3-carboxylic acid".
- Q19596736 pubchem "51049972".
- Q19596736 thumbnail Dasolampanel.svg?width=300.
- Q19596736 wikiPageWikiLink Q1088113.
- Q19596736 wikiPageWikiLink Q133823.
- Q19596736 wikiPageWikiLink Q19597602.
- Q19596736 wikiPageWikiLink Q20870725.
- Q19596736 wikiPageWikiLink Q21098868.
- Q19596736 wikiPageWikiLink Q295251.
- Q19596736 wikiPageWikiLink Q3454536.
- Q19596736 wikiPageWikiLink Q461809.
- Q19596736 wikiPageWikiLink Q485014.
- Q19596736 wikiPageWikiLink Q4926095.
- Q19596736 wikiPageWikiLink Q5156356.
- Q19596736 wikiPageWikiLink Q6184475.
- Q19596736 wikiPageWikiLink Q640448.
- Q19596736 wikiPageWikiLink Q7145142.
- Q19596736 wikiPageWikiLink Q7215865.
- Q19596736 wikiPageWikiLink Q7708612.
- Q19596736 wikiPageWikiLink Q7825858.
- Q19596736 wikiPageWikiLink Q824258.
- Q19596736 wikiPageWikiLink Q8367244.
- Q19596736 wikiPageWikiLink Q8569934.
- Q19596736 wikiPageWikiLink Q8844648.
- Q19596736 wikiPageWikiLink Q8919936.
- Q19596736 wikiPageWikiLink Q9546190.
- Q19596736 atcPrefix "None".
- Q19596736 casNumber "503294".
- Q19596736 iupacName "-6".
- Q19596736 pubchem "51049972".
- Q19596736 unii "1".
- Q19596736 type ChemicalSubstance.
- Q19596736 type Drug.
- Q19596736 type ChemicalObject.
- Q19596736 type Thing.
- Q19596736 type Q8386.
- Q19596736 comment "Dasolampanel (INN, USAN, code name NGX-426) is an orally bioavailable analog of tezampanel and thereby competitive antagonist of the AMPA and kainate receptors which was under development by Raptor Pharmaceuticals/Torrey Pines Therapeutics for the treatment of chronic pain conditions including neuropathic pain and migraine.".
- Q19596736 label "Dasolampanel".
- Q19596736 depiction Dasolampanel.svg.